Citation: J. Soongswang et al., Outcomes of transcatheter balloon angioplasty of obstruction in the neo-aortic arch after the Norwood operation, CARD YOUNG, 11(1), 2001, pp. 54-61
Authors:
Davis, JA
Cecchin, F
Jones, TK
Portman, MA
Citation: Ja. Davis et al., Major coronary artery anomalies in a pediatric population: Incidence and clinical importance, J AM COL C, 37(2), 2001, pp. 593-597
Authors:
Slee, DH
Romano, SJ
Yu, JH
Nguyen, TN
John, JK
Raheja, NK
Axe, FU
Jones, TK
Ripka, WC
Citation: Dh. Slee et al., Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity, J MED CHEM, 44(13), 2001, pp. 2094-2107
Authors:
Duncan, BW
Rosenthal, GL
Jones, TK
Lupinetti, FM
Citation: Bw. Duncan et al., First-stage palliation of complex univentricular cardiac anomalies in older infants, ANN THORAC, 72(6), 2001, pp. 2077-2080
Citation: Rg. Grifka et Tk. Jones, Transcatheter closure of large PDA using 0.052 '' Gianturco coils: Controlled delivery using a bioptome catheter through a 4 French sheath, CATHET C IN, 49(3), 2000, pp. 301-306
Authors:
Kong, JW
Hamann, LG
Ruppar, DA
Edwards, JP
Marschke, KB
Jones, TK
Citation: Jw. Kong et al., Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quinolines, BIOORG MED, 10(5), 2000, pp. 411-414
Citation: Jl. Coleman et al., Seismic resolution of submarine channel architecture as indicated by outcrop analogs, AAPG MEMOIR, 72(68), 2000, pp. 119-126
Authors:
Starnes, SL
Duncan, BW
Kneebone, JM
Rosenthal, GL
Jones, TK
Grifka, RG
Cecchin, F
Owens, DJ
Fearneyhough, C
Lupinetti, FM
Citation: Sl. Starnes et al., Vascular endothelial growth factor and basic fibroblast growth factor in children with cyanotic congenital heart disease, J THOR SURG, 119(3), 2000, pp. 534-539
Citation: Tk. Jones et al., Right aortic arch with isolation of the left subclavian artery, moderate patent ductus arteriosus, and subclavian steal syndrome: A rare aortic arch anomaly treated with the Gianturco-Grifka Vascular Occlusion Device, CATHET C IN, 47(3), 1999, pp. 320-322
Authors:
Edwards, JP
Higuchi, RI
Winn, DT
Pooley, CLF
Caferro, TR
Hamann, LG
Zhi, L
Marschke, KB
Goldman, ME
Jones, TK
Citation: Jp. Edwards et al., Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, BIOORG MED, 9(7), 1999, pp. 1003-1008
Citation: L. Zhi et al., Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone, BIOORG MED, 9(7), 1999, pp. 1009-1012
Authors:
Stefanelli, CB
Stevenson, JG
Jones, TK
Lester, JR
Cecchin, F
Citation: Cb. Stefanelli et al., A case for routine screening of coronary artery origins during echocardiography: Fortuitous discovery of a life-threatening coronary anomaly, J AM S ECHO, 12(9), 1999, pp. 769-772
Citation: Ns. Mani et al., Addition of Grignard reagents to quinolinium salts: Evidence for a unique redox reaction between a 1,4-and a 1,2-dihydroquinoline, J ORG CHEM, 64(18), 1999, pp. 6911-6914
Authors:
Zhi, L
Tegley, CM
Marschke, KB
Mais, DE
Jones, TK
Citation: L. Zhi et al., 5-aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: Effect of A-ring modification, J MED CHEM, 42(8), 1999, pp. 1466-1472
Citation: Lg. Hamann et al., Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6(trifluoromethyl)-8-pyridono[5,6-g]-quinoline (LG121071), J MED CHEM, 42(2), 1999, pp. 210-212
Authors:
Zhi, L
Tegley, CM
Edwards, JP
West, SJ
Marschke, KB
Gottardis, MM
Mais, DE
Jones, TK
Citation: L. Zhi et al., 5-alkyl 1,2-dihydrochromeno[3,4-f]quinolines: A novel class of nonsteroidal progesterone receptor modulators, BIOORG MED, 8(23), 1998, pp. 3365-3370